Early-Stage Bladder Cancer Surveillance Does Not Improve Survival If High-Risk Patients Are Permitted to Progress to Muscle Invasion
Author:
Publisher
Elsevier BV
Subject
Urology
Reference19 articles.
1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006
2. Long-term survival of patients with bladder tumours: the significance of risk factors;Zieger;Br J Urol,1998
3. Recurrence and progression in low grade papillary urothelial tumors;Holmang;J Urol,1999
4. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997
5. The application of a prognostic factor analysis for Ta-T1 bladder cancer in routine urological practice;Reading;Br J Urol,1995
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status;Urologic Oncology: Seminars and Original Investigations;2024-10
2. Clinical Trial Protocol for “Replace Cysto”: Replacing Invasive Cystoscopy with Urine Testing for Non–muscle-invasive Bladder Cancer Surveillance—A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy;European Urology Open Science;2024-05
3. Prognostic variations between ‘primary’ and ‘progressive’ muscle-invasive bladder cancer following radical cystectomy: a novel propensity score-based multicenter cohort study;International Journal of Surgery;2023-09-21
4. Role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer;African Journal of Urology;2023-03-30
5. Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG;Clinical Genitourinary Cancer;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3